Astal Laboratories Fund Raise of ₹3.06 Cr

Astal Laboratories Other Announcement

Astal Laboratories submitted the Regulation 74(5) certificate from its Registrar for the quarter ended September 30, 2026, confirming the dematerialization activities.

Astal Laboratories Other Announcement

Astal Laboratories' material subsidiary, Sriven Pharmachem India, appointed new Internal, Cost, and Secretarial Auditors. The appointments were approved during the subsidiary's board meeting on September 28, 2026.

Astal Laboratories Management Change

Astal Laboratories Limited has appointed Ms. Ambika Kedia as Company Secretary of its material wholly-owned subsidiary, Sriven Pharmachem India Private Limited. The appointment is effective from September 28, 2026.

Astal Laboratories Annual General Meeting

Astal Laboratories held its 33rd Annual General Meeting on September 29, 2026. Members transacted business regarding financial statements and the re-appointment of a director.

Astal Laboratories Promoter Buying: ₹0.2 Cr

Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.

Value

₹0.20 Cr

Promoter stake change

+0.06%

Astal Laboratories Promoter Buying

Astal Laboratories' promoter ACESO Research Labs LLP bought equity shares on BSE under a SEBI PIT disclosure. The open-market purchase signals promoter confidence.

Cholamandalam Investment & Finance Company Fund Raise

Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.

Bodhi Tree Multimedia Fund Raise

Bodhi Tree Multimedia's EOGM on October 28, 2026, sought approval for a qualified institutions placement. The filing states no issue size.

Avalon Technologies Fund Raise of ₹425 Cr

Avalon Technologies' board approved a preferential warrant issue to Zollner Elektronik AG worth about ₹425 Crore. Shareholder approval is required at an EGM on 21 November 2026.

Value

₹425.0 Cr

Execution

Warrants exercisable within 18 months from allotment

Sealmatic India Fund Raise of ₹15.01 Cr

Sealmatic India's board approved a ₹15.01 Crore preferential issue of 3,61,620 equity shares at ₹415 to two non-promoter investors. Shareholder approval at EGM is pending.

Value

₹15.01 Cr

Sky Gold and Diamonds Fund Raise of ₹1,800 Cr

Sky Gold and Diamonds' EGM on 18 November 2026 seeks approval to raise up to ₹1,800 crore via equity-linked securities. Remote e-voting closes 17 November 2026.

Value

₹1,800 Cr

Fynx Capital Fund Raise of ₹80 Cr

Fynx Capital's board approved a rights issue of up to Rs.80 Crore at a 4:1 ratio. The Rights Issue Committee will approve the draft letter of offer.

Value

₹80.00 Cr